ClinTec Launches Global Academy of Clinical Research Excellence Focusing on Training Clinical Professionals
News Jun 08, 2010
ClinTec International announces the opening of its Global Academy of Clinical Research Excellence “ACRE”, at the 2010 PABME (Pharmaceutical and Biotechnology Middle East) conference in Dubai, UAE.
The ACRE training courses which have been accredited by the Dubai Health Authority have admitted the first students for training in ICH-GCP. The academy is set to provide the MENA region with a significant resource for training and educating professionals in clinical research techniques, methods and practices. The academy’s mission is to accelerate knowledge growth and to increase the level and quality of clinical research carried out in Middle East.
ClinTec has individually recruited and selected the academy’s staff. With plans to roll-out academies in other emerging markets such as India, China and Latin America, staff at ACRE have been selected for their local knowledge and understanding of the local clinical research market and its specific needs.
Dr Rabinder Buttar, CEO of ClinTec International commented: “A major healthcare challenge in the MENA region has been the capacity to develop the knowledge of local investigators to levels in which they fully understand the complex nuances required in international clinical trials. The most effective way to make clinical research more meaningful is to have a thorough knowledge of the processes and procedures involved in research. Our experience has shown that cultivating a learning curve is imperative for professional success.”
Autism Risk Higher if Pregnant Mothers Have Infection Requiring HospitalizationNews
Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.READ MORE
£2.2M Collaboration to Fuel Drug Developments for HIVNews
A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further £2.2M ($3M) to develop sophisticated new medicines for HIV.READ MORE
Antibody Treatment Effective in Treatment-Resistant COPD PatientsNews
The new study reports the results from two Phase III clinical trials evaluating the efficacy of mepolizumab, an antibody treatment that reduces the number of eosinophils in the blood, in moderate to severe treatment-resistant eosinophilic COPD.READ MORE